EARLY PRESCRIPTION OF PLATELET P2Y12 RECEPTOR INHIBITORS TO PATIENTS WITH ACUTE CORONARY SYNDROME: A BENEFIT OR A HARM?
Double antiplatelet therapy, which includes aspirin and platelet P2Y12 receptor inhibitors (hereinafter P2Y12 inhibitor) is the main component of treatment and secondary prevention after ACS. In recent years, the issue of determining whether it is expedient for P2Y12 inhibitors to be early prescribe...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«REMEDIUM GROUP» Ltd.
2018-12-01
|
| Series: | Атеротромбоз |
| Subjects: | |
| Online Access: | https://www.aterotromboz.ru/jour/article/view/168 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850182207855919104 |
|---|---|
| author | Roman M. Shakhnovich |
| author_facet | Roman M. Shakhnovich |
| author_sort | Roman M. Shakhnovich |
| collection | DOAJ |
| description | Double antiplatelet therapy, which includes aspirin and platelet P2Y12 receptor inhibitors (hereinafter P2Y12 inhibitor) is the main component of treatment and secondary prevention after ACS. In recent years, the issue of determining whether it is expedient for P2Y12 inhibitors to be early prescribed to patients with ACS – prior to coronary angiography, when coronary anatomy is unknown – has been widely debated. The review provides comprehensive up-to-date information on this topic based on data from randomized trials, registers, and official clinical guidelines. |
| format | Article |
| id | doaj-art-3d653318ec744cf6a70416306ca51368 |
| institution | OA Journals |
| issn | 2307-1109 2658-5952 |
| language | Russian |
| publishDate | 2018-12-01 |
| publisher | «REMEDIUM GROUP» Ltd. |
| record_format | Article |
| series | Атеротромбоз |
| spelling | doaj-art-3d653318ec744cf6a70416306ca513682025-08-20T02:17:41Zrus«REMEDIUM GROUP» Ltd.Атеротромбоз2307-11092658-59522018-12-0102768610.21518/2307-1109-2018-2-76-86148EARLY PRESCRIPTION OF PLATELET P2Y12 RECEPTOR INHIBITORS TO PATIENTS WITH ACUTE CORONARY SYNDROME: A BENEFIT OR A HARM?Roman M. Shakhnovich0National Medical Research Centre of Cardiology, Federal State Budgetary Institution of the Ministry of Health of the Russian FederationDouble antiplatelet therapy, which includes aspirin and platelet P2Y12 receptor inhibitors (hereinafter P2Y12 inhibitor) is the main component of treatment and secondary prevention after ACS. In recent years, the issue of determining whether it is expedient for P2Y12 inhibitors to be early prescribed to patients with ACS – prior to coronary angiography, when coronary anatomy is unknown – has been widely debated. The review provides comprehensive up-to-date information on this topic based on data from randomized trials, registers, and official clinical guidelines.https://www.aterotromboz.ru/jour/article/view/168acutecoronary syndromeplatelet p2y12 receptor inhibitorsclopidogrelticagrelorprasugrel |
| spellingShingle | Roman M. Shakhnovich EARLY PRESCRIPTION OF PLATELET P2Y12 RECEPTOR INHIBITORS TO PATIENTS WITH ACUTE CORONARY SYNDROME: A BENEFIT OR A HARM? Атеротромбоз acutecoronary syndrome platelet p2y12 receptor inhibitors clopidogrel ticagrelor prasugrel |
| title | EARLY PRESCRIPTION OF PLATELET P2Y12 RECEPTOR INHIBITORS TO PATIENTS WITH ACUTE CORONARY SYNDROME: A BENEFIT OR A HARM? |
| title_full | EARLY PRESCRIPTION OF PLATELET P2Y12 RECEPTOR INHIBITORS TO PATIENTS WITH ACUTE CORONARY SYNDROME: A BENEFIT OR A HARM? |
| title_fullStr | EARLY PRESCRIPTION OF PLATELET P2Y12 RECEPTOR INHIBITORS TO PATIENTS WITH ACUTE CORONARY SYNDROME: A BENEFIT OR A HARM? |
| title_full_unstemmed | EARLY PRESCRIPTION OF PLATELET P2Y12 RECEPTOR INHIBITORS TO PATIENTS WITH ACUTE CORONARY SYNDROME: A BENEFIT OR A HARM? |
| title_short | EARLY PRESCRIPTION OF PLATELET P2Y12 RECEPTOR INHIBITORS TO PATIENTS WITH ACUTE CORONARY SYNDROME: A BENEFIT OR A HARM? |
| title_sort | early prescription of platelet p2y12 receptor inhibitors to patients with acute coronary syndrome a benefit or a harm |
| topic | acutecoronary syndrome platelet p2y12 receptor inhibitors clopidogrel ticagrelor prasugrel |
| url | https://www.aterotromboz.ru/jour/article/view/168 |
| work_keys_str_mv | AT romanmshakhnovich earlyprescriptionofplateletp2y12receptorinhibitorstopatientswithacutecoronarysyndromeabenefitoraharm |